Why Is Cancer-Focused Penny Stock Viracta Therapeutics Trading Higher On Wednesday? – Benzinga

Penny stock Viracta Therapeutics is seeing an increase in trading on Wednesday. The company, which focuses on cancer treatment, is experiencing higher trading volumes. Investors seem to be showing interest in the potential of the company in the cancer treatment sector. Viracta Therapeutics’ stock price is on the rise as a result of this increased trading activity.